Par Drugs & Chemicals Share Price
Start SIP in Par Drugs & Chemicals
Start SIPPar Drugs & Chemicals Performance
Day Range
- Low 240
- High 259
52 Week Range
- Low 180
- High 325
- Open Price246
- Previous Close246
- Volume55802
Par Drugs & Chemicals Investment Rating
-
Master Rating:
-
Par Drugs and Chemicals has an operating revenue of Rs. 95.31 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 20% is great, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 7% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 23 | 23 | 24 | 26 | 23 | 24 |
| Operating Expenses Qtr Cr | 18 | 17 | 19 | 19 | 19 | 19 |
| Operating Profit Qtr Cr | 4 | 6 | 5 | 7 | 4 | 5 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 1 | 1 | 1 | 2 | 1 | 1 |
| Net Profit Qtr Cr | 3 | 4 | 3 | 5 | 2 | 3 |
Par Drugs & Chemicals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹243.69
- 50 Day
- ₹240.96
- 100 Day
- ₹237.89
- 200 Day
- ₹229.43
- 20 Day
- ₹243.79
- 50 Day
- ₹240.22
- 100 Day
- ₹241.11
- 200 Day
- ₹229.79
Par Drugs & Chemicals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 254.03 |
| Second Resistance | 265.97 |
| Third Resistance | 273.03 |
| RSI | 49.45 |
| MFI | 70.55 |
| MACD Single Line | 1.89 |
| MACD | 2.14 |
| Support | |
|---|---|
| First Support | 235.03 |
| Second Support | 227.97 |
| Third Supoort | 216.03 |
Par Drugs & Chemicals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 55,802 | 1,963,672 | 35.19 |
| Week | 93,395 | 3,775,960 | 40.43 |
| 1 Month | 47,296 | 2,737,492 | 57.88 |
| 6 Month | 61,354 | 2,503,867 | 40.81 |
Par Drugs & Chemicals Result Highlights
Par Drugs & Chemicals Synopsis
NSE-Medical-Diversified
Par Drugs & Chemical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 95.64 Cr. and Equity Capital is Rs. 12.30 Cr. for the Year ended 31/03/2024. Par Drugs & Chemicals Ltd. is a Public Limited Listed company incorporated on 26/02/1999 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24117GJ1999PLC035512 and registration number is 035512.| Market Cap | 303 |
| Sales | 95 |
| Shares in Float | 0.32 |
| No of funds | 3 |
| Yield | 0.72 |
| Book Value | 3.54 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | |
| Alpha | 0.07 |
| Beta | 0.59 |
Par Drugs & Chemicals Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 74.21% | 74.21% | 74.21% | 74.21% |
| Foreign Portfolio Investors | 0.32% | 0.07% | 0.07% | |
| Individual Investors | 20.09% | 20.45% | 21.23% | 21.4% |
| Others | 5.38% | 5.27% | 4.49% | 4.39% |
Par Drugs & Chemicals Management
| Name | Designation |
|---|---|
| Mr. Falgun Vallabhbhai Savani | Chairman & Managing Director |
| Mr. Jignesh Vallabhbhai Savani | Executive Director & CEO |
| Mr. Ghanshayambhai Bhagvanbhai Savani | Whole Time Director |
| Mrs. Nayna Jignesh Savani | Non Executive Director |
| Mr. Pravin Manjibhai Bhayani | Independent Director |
| Mrs. Kajal Chintanbhai Vaghani | Independent Director |
| Mrs. Krishna Mitulbhai Shah | Independent Director |
| Mrs. Bintal Bhaveshkumar Shah | Independent Director |
Par Drugs & Chemicals Forecast
Price Estimates
Par Drugs & Chemicals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-17 | Others | To consider other business matters issue in the ratio of 1:1 of Rs. 10/-. |
| 2024-08-03 | Quarterly Results | |
| 2024-05-09 | Audited Results & Others | |
| 2024-02-16 | Quarterly Results | (Revised) issue in the ratio of 1:1 of Rs. 10/-. |
| 2023-10-28 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2021-04-28 | Bonus | Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-. |
Par Drugs & Chemicals FAQs
What is Share Price of Par Drugs & Chemicals ?
Par Drugs & Chemicals share price is ₹242 As on 18 September, 2024 | 02:29
What is the Market Cap of Par Drugs & Chemicals ?
The Market Cap of Par Drugs & Chemicals is ₹297.9 Cr As on 18 September, 2024 | 02:29
What is the P/E ratio of Par Drugs & Chemicals ?
The P/E ratio of Par Drugs & Chemicals is 20.5 As on 18 September, 2024 | 02:29
What is the PB ratio of Par Drugs & Chemicals ?
The PB ratio of Par Drugs & Chemicals is 3.5 As on 18 September, 2024 | 02:29